BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25250324)

  • 1. L-methionase: a therapeutic enzyme to treat malignancies.
    Sharma B; Singh S; Kanwar SS
    Biomed Res Int; 2014; 2014():506287. PubMed ID: 25250324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylserine: A cancer cell targeting biomarker.
    Sharma B; Kanwar SS
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):17-25. PubMed ID: 28870843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey.
    Hoffman RM
    Expert Opin Biol Ther; 2015 Jan; 15(1):21-31. PubMed ID: 25439528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine dependency and cancer treatment.
    Cellarier E; Durando X; Vasson MP; Farges MC; Demiden A; Maurizis JC; Madelmont JC; Chollet P
    Cancer Treat Rev; 2003 Dec; 29(6):489-99. PubMed ID: 14585259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine dependence in cancer cells - a review.
    Hoffman RM
    In Vitro; 1982 May; 18(5):421-8. PubMed ID: 6749653
    [No Abstract]   [Full Text] [Related]  

  • 6. The methionase chain reaction: an enzyme-based autocatalytic amplification system for the detection of thiols.
    Adams JD; Røise JJ; Lee DS; Murthy N
    Chem Commun (Camb); 2020 Mar; 56(21):3175-3178. PubMed ID: 32065188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.
    Stone E; Paley O; Hu J; Ekerdt B; Cheung NK; Georgiou G
    ACS Chem Biol; 2012 Nov; 7(11):1822-9. PubMed ID: 22963240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture.
    Kreis W; Baker A; Ryan V; Bertasso A
    Cancer Res; 1980 Mar; 40(3):634-41. PubMed ID: 6937240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methioninase: a therapeutic for diseases related to altered methionine metabolism and transmethylation: cancer, heart disease, obesity, aging, and Parkinson's disease.
    Hoffman RM
    Hum Cell; 1997 Mar; 10(1):69-80. PubMed ID: 9234067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Recombinant Methioninase for Cancer Treatment.
    Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
    Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6.
    Gay F; Aguera K; Sénéchal K; Tainturier A; Berlier W; Maucort-Boulch D; Honnorat J; Horand F; Godfrin Y; Bourgeaux V
    Cancer Med; 2017 Jun; 6(6):1437-1452. PubMed ID: 28544589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular and biochemical principles of neoplasm enzyme therapy].
    Berezov TT
    Biomed Khim; 2005; 51(3):235-47. PubMed ID: 16104387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methioninase Gene Therapy.
    Hoffman RM; Miki K; Al-Refaie W; Xu M; Tan Y
    Methods Mol Biol; 2019; 1866():173-197. PubMed ID: 30725416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review.
    Kawaguchi K; Han Q; Li S; Tan Y; Igarashi K; Murakami T; Unno M; Hoffman RM
    Cells; 2019 May; 8(5):. PubMed ID: 31052611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial L-methioninase: production, molecular characterization, and therapeutic applications.
    El-Sayed AS
    Appl Microbiol Biotechnol; 2010 Mar; 86(2):445-67. PubMed ID: 20146062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future.
    Javia BM; Gadhvi MS; Vyas SJ; Ghelani A; Wirajana N; Dudhagara DR
    Int J Biol Macromol; 2024 Apr; 265(Pt 2):130997. PubMed ID: 38508568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension.
    Cavuoto P; Fenech MF
    Cancer Treat Rev; 2012 Oct; 38(6):726-36. PubMed ID: 22342103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic action of L-methionine gamma-lyase on selenomethionine and selenols.
    Esaki N; Tanaka H; Uemura S; Suzuki T; Soda K
    Biochemistry; 1979 Feb; 18(3):407-10. PubMed ID: 420789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide.
    Krais JJ; Virani N; McKernan PH; Nguyen Q; Fung KM; Sikavitsas VI; Kurkjian C; Harrison RG
    Mol Cancer Ther; 2017 Sep; 16(9):1855-1865. PubMed ID: 28522586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
    Guillen KP; Restuccia A; Kurkjian C; Harrison RG
    Pancreas; 2015 Aug; 44(6):945-52. PubMed ID: 25899647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.